Analysis of The Use of Antimicrobial Drugs in Patients who were Diagnosed as Community-Acquired Pneumonia During 2004~2005
- VernacularTitle:2004～2005年社区获得性肺炎患者抗菌药物使用情况分析
- Author:
Yafang LI
;
Xiaohua ZHANG
- Publication Type:Journal Article
- Keywords:
Community acquired pneumonia;
Antibacterial;
Medicine analysis
- From:
Journal of Medical Research
2006;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective Depending on the analysis of patients who were diagnosed as Community-Acquired Pneumonia in our hospital during 2004-2005, we compared with 《Directory for Diagnose of Community-Acquired Pneumonia》(Draft) in order to provide the guidance for the rational antimicrobial use in clinic. Methods Using the Retrospective Analyze method,we analyzed the cases which included: Name, Sex, Age, time during in hospital, Fees, Medicine and Note. Results Compared from 2005 with 2004, the top 3 ranks of the DDDs in 2004 were cefoperazone sodium/sulbactam sodium;L-ofloxacin ; etimicin and in 2005 were L-ofloxacin; cefoperazone sodium/sulbactam; etimicin. The rate of medicine fees were decreased,but the unites to use medicine,the average time in hospital and the average medicine fees were not deferent remarkable. Conclusions After 《Directory for Diagnose of Community-Acquired Pneumonia》(Draft) was carried out,the condition of application was more rational in 2005 than in 2004, but there were still many problems should be improved.
